Zuffa, LLC, owner of the Ultimate Fighting Championship®, released a statement today regarding UFC flyweight Ali Bagautinov:
“UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO). He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes. Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.”
Fans voices come first
Favorite athlete? Fantasy match-ups? Comments? Leave 'em here!
UFC Announces Launch Of Direct-To-Consumer Streaming…
UFC Fight Pass To Become New Home In Brazil For All UFC Events Starting Jan. 1, 2023